Literature DB >> 18655064

SAR by oxime-containing peptide libraries: application to Tsg101 ligand optimization.

Fa Liu1, Andrew G Stephen, Abdul A Waheed, M Javad Aman, Eric O Freed, Robert J Fisher, Terrence R Burke.   

Abstract

HIV-1 viral assembly requires a direct interaction between a Pro-Thr-Ala-Pro ("PTAP") motif in the viral protein Gag-p6 and the cellular endosomal sorting factor Tsg101. In an effort to develop competitive inhibitors of this interaction, an SAR study was conducted based on the application of post solid-phase oxime formation involving the sequential insertion of aminooxy-containing residues within a nonamer parent peptide followed by reaction with libraries of aldehydes. Approximately 15-20-fold enhancement in binding affinity was achieved by this approach.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18655064      PMCID: PMC2581409          DOI: 10.1002/cbic.200800281

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  22 in total

1.  Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding.

Authors:  J E Garrus; U K von Schwedler; O W Pornillos; S G Morham; K H Zavitz; H E Wang; D A Wettstein; K M Stray; M Côté; R L Rich; D G Myszka; W I Sundquist
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

2.  Structure and functional interactions of the Tsg101 UEV domain.

Authors:  Owen Pornillos; Steven L Alam; Rebecca L Rich; David G Myszka; Darrell R Davis; Wesley I Sundquist
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

3.  Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein.

Authors:  Owen Pornillos; Steven L Alam; Darrell R Davis; Wesley I Sundquist
Journal:  Nat Struct Biol       Date:  2002-11

Review 4.  Protein-protein interactions as targets for antiviral chemotherapy.

Authors:  Arianna Loregian; Howard S Marsden; Giorgio Palù
Journal:  Rev Med Virol       Date:  2002 Jul-Aug       Impact factor: 6.989

5.  The HIV-TSG101 interface: recent advances in a budding field.

Authors:  Eric O Freed
Journal:  Trends Microbiol       Date:  2003-02       Impact factor: 17.079

Review 6.  The next generation of HIV/AIDS drugs: novel and developmental antiHIV drugs and targets.

Authors:  Jim A Turpin
Journal:  Expert Rev Anti Infect Ther       Date:  2003-06       Impact factor: 5.091

7.  Exploiting the basis of proline recognition by SH3 and WW domains: design of N-substituted inhibitors.

Authors:  J T Nguyen; C W Turck; F E Cohen; R N Zuckermann; W A Lim
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

8.  A highly potent and selective PKCalpha inhibitor generated via combinatorial modification of a peptide scaffold.

Authors:  Jung Hwan Lee; Sandip K Nandy; David S Lawrence
Journal:  J Am Chem Soc       Date:  2004-03-24       Impact factor: 15.419

9.  Late domain-dependent inhibition of equine infectious anemia virus budding.

Authors:  Miranda Shehu-Xhilaga; Sherimay Ablan; Dimiter G Demirov; Chaoping Chen; Ronald C Montelaro; Eric O Freed
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

10.  Protected aminooxyprolines for expedited library synthesis: application to Tsg101-directed proline-oxime containing peptides.

Authors:  Fa Liu; Andrew G Stephen; Robert J Fisher; Terrence R Burke
Journal:  Bioorg Med Chem Lett       Date:  2007-12-07       Impact factor: 2.823

View more
  16 in total

Review 1.  Proline-rich regions and motifs in trafficking: from ESCRT interaction to viral exploitation.

Authors:  Xuefeng Ren; James H Hurley
Journal:  Traffic       Date:  2011-05-13       Impact factor: 6.215

2.  Value of MR contrast media in image-guided body interventions.

Authors:  Maythem Saeed; Mark Wilson
Journal:  World J Radiol       Date:  2012-01-28

3.  Crystallographic and functional analysis of the ESCRT-I /HIV-1 Gag PTAP interaction.

Authors:  Young Jun Im; Lillian Kuo; Xuefeng Ren; Patricia V Burgos; Xue Zhi Zhao; Fa Liu; Terrence R Burke; Juan S Bonifacino; Eric O Freed; James H Hurley
Journal:  Structure       Date:  2010-11-10       Impact factor: 5.006

4.  Targeting Protein-Protein Interactions of Tyrosine Phosphatases with Microarrayed Fragment Libraries Displayed on Phosphopeptide Substrate Scaffolds.

Authors:  Megan Hogan; Medhanit Bahta; Kohei Tsuji; Trung X Nguyen; Scott Cherry; George T Lountos; Joseph E Tropea; Bryan M Zhao; Xue Zhi Zhao; David S Waugh; Terrence R Burke; Robert G Ulrich
Journal:  ACS Comb Sci       Date:  2019-01-31       Impact factor: 3.784

Review 5.  Novel approaches to inhibiting HIV-1 replication.

Authors:  Catherine S Adamson; Eric O Freed
Journal:  Antiviral Res       Date:  2009-09-24       Impact factor: 5.970

Review 6.  HIV type 1 Gag as a target for antiviral therapy.

Authors:  Abdul A Waheed; Eric O Freed
Journal:  AIDS Res Hum Retroviruses       Date:  2011-09-21       Impact factor: 2.205

7.  Oxime-based linker libraries as a general approach for the rapid generation and screening of multidentate inhibitors.

Authors:  Medhanit Bahta; Fa Liu; Sung-Eun Kim; Andrew G Stephen; Robert J Fisher; Terrence R Burke
Journal:  Nat Protoc       Date:  2012-03-15       Impact factor: 13.491

8.  Utilization of nitrophenylphosphates and oxime-based ligation for the development of nanomolar affinity inhibitors of the Yersinia pestis outer protein H (YopH) phosphatase.

Authors:  Medhanit Bahta; George T Lountos; Beverly Dyas; Sung-Eun Kim; Robert G Ulrich; David S Waugh; Terrence R Burke
Journal:  J Med Chem       Date:  2011-03-28       Impact factor: 7.446

9.  Elucidation of New Binding Interactions with the Tumor Susceptibility Gene 101 (Tsg101) Protein Using Modified HIV-1 Gag-p6 Derived Peptide Ligands.

Authors:  Sung-Eun Kim; Fa Liu; Young Jun Im; Andrew G Stephen; Matthew J Fivash; Abdul A Waheed; Eric O Freed; Robert J Fisher; James H Hurley; Terrence R Burke
Journal:  ACS Med Chem Lett       Date:  2011-05-12       Impact factor: 4.345

10.  Enhancing polo-like kinase 1 selectivity of polo-box domain-binding peptides.

Authors:  Xue Zhi Zhao; David Hymel; Terrence R Burke
Journal:  Bioorg Med Chem       Date:  2017-02-28       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.